|
Naltrexone, Craving, and Drinking Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Naltrexone, Craving, and Drinking conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Naltrexone, Craving, and Drinking Clinical research trials and Naltrexone, Craving, and Drinking healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Naltrexone, Craving, and Drinking. Naltrexone, Craving, and Drinking Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Naltrexone, Craving, and Drinking clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Naltrexone, Craving, and Drinking condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Naltrexone, Craving, and Drinking  Naltrexone, Craving, and Drinking
Naltrexone, Craving, and Drinking
For Condition: Alcoholism
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates, and reaction to drinking-related triggers, or cues, in participants' everyday environment and in laboratory sessions. Participants will monitor and record their daily desires to drink, environmental circumstances in which urges occur, and drinking behavior using a palm top computer. Participants will receive naltrexone or a placebo. One week after receiving medication, all participants will be asked to respond to alcohol-related cues that may or may not arouse the desire to drink.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 21 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Drink at least 4 days per week with 2 heavy drinking days (more than 6 standard drinks for men, more than 5 drinks for women) per week on average during the month prior to the study. Exclusion Criteria: - Current interest in treatment or a history of treatment for alcohol problems. - History of liver disease or current liver function tests greater than five times normal. - Opiate abuse or dependence, any opiate use two weeks before the study or a urine test screen that is positive for opiates. - Females, who are pregnant, nursing, or not using reliable birth control method. - Daily use of acetaminophen. - Living with someone who participated in this study.
Total Enrollment: 186
Location and Contact Information:
Center for Alcohol and Addiction Studies, Brown University *Recruiting*
Providence, Rhode Island, 02919
United States
Recruiting Dr. Monti 401-444-1849
Additional Information:
Study ID Numbers: NIAAAMON0785011A1;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006203
Other Alcoholism Studies:
1. Drug Therapy for Alcohol Dependence in Alaska Natives (naltrexone/sertraline)
2. Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
3. Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)
4. Naltrexone for Relapse Prevention
5. Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens
Related Studies:
Other Alcoholism Clinical Trials
Other Rhode Island Clinical Trials
Other Providence Clinical Trials
Naltrexone, Craving, and Drinking
|
|
|
|
|
|
|
|
